🏅 FDA Orphan Designation

Ornidyl

Eflornithine HCl

Manufacturer: Hoechst Marion Roussel

Indicated for:

Progressive autosomal recessive ataxia-deafness syndromeOrphan

FDA-Approved Indications (1)

Progressive autosomal recessive ataxia-deafness syndromeOrphan Designation

💙 Support Programs

View all →

Ornidyl

Hoechst Marion Roussel

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.